Advances in cell and protein analysis for virology research - Sartorius
The Drug Discovery World Podcast
Release Date: 04/14/2021
The next generation of respiratory therapeutics
The Drug Discovery World Podcast
In theseries, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business. In this episode, Megan Thomas is in conversation with Dimitrios Goundis, CEO of Kither Biotech. Kither is a Phase I, soon to be Phase II, Italian biotech focused on respiratory diseases such as cystic fibrosis. This episode explores how emerging biotech strategies are advancing treatments for respiratory diseases like cystic fibrosis, with a focus on targeted drug delivery, clinical trial progression, and the...
info_outline
DDW Highlights: 7 May 2025
The Drug Discovery World Podcast
The latest episode of the is now available. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. With the taking place from 25-30 April, the DDW news desk has been inundated with the latest advances in cancer drug discovery, so here are a few highlights. Check out our for more updates. You can listen here, or find The Drug Discovery World Podcast on , and
info_outline
An overview on the impact of synthetic biology
The Drug Discovery World Podcast
This is the latest episode of the free DDW narrated podcast, titled “An overview on the impact of synthetic biology”, which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “” and “” In the first article, Mark Kotter, Founder and CEO of bit.bio, talks with Reece Armstrong about different approaches to synthetic biology and its applications in programming stem cells into mature, functional human cells for drug discovery and the creation of next generation. In the second article, Reece Armstrong examines recent activity within the synthetic...
info_outline
DDW Highlights: 28 April 2025
The Drug Discovery World Podcast
The latest episode of the is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. With Eli Lilly so far winning the race to bring an oral GLP-1 drug to market, having announced positive topline results from a Phase III trial, this week our news highlights focus on clinical studies. You can listen below, or find The Drug Discovery World Podcast on , and
info_outline
Where are scientists making waves in drug discovery?
The Drug Discovery World Podcast
This is the latest episode of the free DDW narrated podcast, titled “Where are scientists making waves in drug discovery?”, which covers three articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “”, “” and “” Cognition Therapeutics recently completed the enrolment of its Phase II SEQUEL trial for patients with mild-to-moderate Alzheimer’s disease. The focus of the trial is to test Cognition Therapeutics’ experimental drug, CT1812 for patients with dementia with Lewy Bodies and dry age-related macular degeneration. In the first article, Reece...
info_outline
DDW Highlights: 22 April 2025
The Drug Discovery World Podcast
The latest episode of the is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. In a week of financial uncertainty for the industry, our round-up focuses on the power of partnership to accelerate drug discovery, from the prevention of respiratory infections, to mapping gene activity in inflammatory bowel disease. You can listen below, or find The Drug Discovery World Podcast on , and
info_outline
How is precision medicine making its mark in drug discovery?
The Drug Discovery World Podcast
This is the latest episode of the free DDW narrated podcast, titled “Innovation enabled by new drug discovery technologies”, which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “” and “”. In the first article, Matt Hill, Founder and CEO of Elegen writes about the importance of innovation in DNA synthesis to address critical bottlenecks in biotherapy development. In the second article, Katie Gillette, Senior Project Leader, Eliza French, Analyst, and Graham Friedman, Analyst, DeciBio, provide an industry overview of the role of the...
info_outline
Getting to know key drug discovery leaders and researchers
The Drug Discovery World Podcast
This is the latest episode of the free DDW narrated podcast, titled “Innovation enabled by new drug discovery technologies”, which covers three articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “”, “” and “”. In the first article, Reece Armstrong speaks to Neil Dhawan, the Co-founder and CEO of Totus Medicines about the company’s approach to drug discovery using fundamental technologies in chemistry, biology and artificial intelligence (AI). In the second article, Megan Thomas looked at a day in the life of Giusy Di Conza, Head of Research at...
info_outline
Where is the innovation and opportunity in the therapeutic antibody market?
The Drug Discovery World Podcast
This is the latest episode of the free DDW narrated podcast, titled “Innovation enabled by new drug discovery technologies”, which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “” and “” In the first article, Katie Abouzahr is the Vice President, Autoantibody Portfolio and Maternal Fetal Disease Area Leader at the Janssen Pharmaceutical Companies of Johnson & Johnson. She speaks with Megan Thomas about the future for Janssen’s investigational medicine nipocalimab and antibody therapeutics at large. In the second article, DDW’s...
info_outline
DDW Highlights: 31 March 2025
The Drug Discovery World Podcast
The latest episode of the is now available to listen. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Weight loss drugs have been making the news this week. As we come to the end of Women’s History Month, two of the covered studies focus on women’s health, specifically the role of weight loss drugs in treating endometriosis and why women have worse side effects from these therapeutics. You can listen below, or find The Drug Discovery World Podcast on , and
info_outlineThis DDW podcast features Dr Hongshan Li, Applications Manager, Sartorius, discussing advances in cell and protein analysis for virology research.
This episode examines virology research - what’s currently happening in the sector and how new advances in technology are helping push forward innovation and drug development. With COVID-19 playing such a significant role in the drug discovery and development industry over the last year, we find out what effect it has had and Dr Li explains how we can take some of the methodologies that have arisen from the pandemic and use them to drive innovation in virology research.
Dr Li provides:
- An overview of current global virology research. Has the need to explore this area of science grown due to the pandemic and if so, where are the opportunities currently for research?
- The pandemic has highlighted the need for more understanding in and knowledge of emerging infectious diseases (EIDs). How has the drug discovery and development sector responded to this and exposed the areas that need to be developed in EIDs?
- Expertise on how to optimise process, get to market faster and more efficiently.
- Insight into Sartorius’ research around coronaviruses and spike proteins as targets for therapeutics.
- Detail about Sartorius and its technologies relevant to this area of research and how this type of technology can help speed up the discovery process.
- A view on the future of virology research - where the areas of opportunity will be looking head and how can the research community prepare itself to be best placed to tackle new emerging threats should they arise?
Dr Li has many years of experience in the development and optimisation of bioassay platforms and is currently focussing on novel assay development.